2024 RX Tier List Rankings
What are the consensus rankings for RX groups? How do many of them compare to top M&A groups on the street? As I'm going through the SA recruiting process right now, any clarity would be helpful.
What are the consensus rankings for RX groups? How do many of them compare to top M&A groups on the street? As I'm going through the SA recruiting process right now, any clarity would be helpful.
+523 | BofA Associate death? | 20 | 1h | |
+149 | Investment Banking US League Table YTD 2024 (FactSet) | 84 | 2h | |
+143 | Big Layoff at Barclays - 5/1/24 | 76 | 1h | |
+87 | “Americans just work harder” | 53 | 15h | |
+83 | Would comitting to ATL İB be stupid? Please give feedback. | 45 | 2d | |
+68 | Sleeping on Jefferies??? | 32 | 13h | |
+66 | A shitter's comprehensive guide to sophomore year recruiting | 7 | 13h | |
+59 | NEED NY RESTAURANT RECOMMENDATIONS | 38 | 2d | |
+57 | What's up with RBC nowadays? | 24 | 9h | |
+50 | 5-Step (Borderline Psycho) Pre-Superday Routine I Used to Land Every IB Internship Offer | 4 | 2d |
Career Resources
From a deal flow perspective relative to headcount:
1A. EVR, PJT
1B. HL
1C. MOE, LAZ, PWP, CVP, GUGG, DUC
From an exits perspective besides gugg and Ducera they should all be relatively comparable. I don’t know people well enough at gugg and Ducera so someone else can comment. I know analysts from all these places get interviews at places like Apollo, Blackstone, KKR, etc. with relative ease. At this point it’s really more on the candidate.
Rx and m&a isn’t sn apples to apples comparison. It’s more of a apples vs pear. If you think there’s a chance you’ll consider growth oriented roles (corp dev, GE, VC) then you should do M&A. If you want to do credit, distressed, more legal oriented stuff then rx would be great
Think it should be more:
tier 1: PJT
tier 2: EVR, HL in that order
PJT has separated from the rest of the pack over the past ~18 months.
Bro what are you smoking? PJT and evercore are literally neck and neck. I don’t even work at Evercore but Look on reorg they and pjt take like 80% of the most topical deals in rx.
HL isn’t the same as those two. There have been a few times HL was once the advisor and later on Evercore/pjt/ended up being the new FA for the group they represented… that’s pretty fucking embarrassing lol
When’s the last time Ducera was on a relevant debtor side
Diebold, Yellow
What are the exits when you enter RX as an MBA associate? Do you get buyside roles at HF or are you considered a career banker? I've heard mixed opinions on it.
unfortunately the career paths might be restricted to CFO of a midwestern trucking company, hoping thats not true though. I dont know very many post MBA bankers that trasitioned to a good buyside
HL average mandate quality isn’t comparable to PJT/EVR/CVP/PWP…go down market and do some very small deals
The reality is the actual EBs have much better platforms / industry teams than HL and aren’t as willing to bottom feed for deals
idk why people hating lol. You're not wrong.
London rankings?
1) PJT
2) HL
Huge gap
3) Everyone else
What happened to the LAZ team? I thought they were good historically
https://www.wsj.com/articles/lazard-fires-top-restructuring-banker-accu…
Among other things
Where do Piper / Baird / Ray J / Miller Buckfire fit in?
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
These are all good firms with strengths and weaknesses. PJT probably the premier name in the space
If you are asking from an analyst perspective who wants best exit opps, I think you put PJT EVR HL and Moelis at the top of the list
Anyone ever see movement from law to Rx? Have a family friend who's a 1st yr. associate in biglaw (V30-50) who wants to make the move, but doesnt do Rx law (does PE/M&A). Not knowledgeable on the Rx space so just curious if you guys see that move often
Facere ratione nemo cumque sapiente dolores. Minima nemo vel fuga cum. Excepturi pariatur enim et blanditiis.
Fugit et autem a quia cumque cumque consequatur. Ab unde excepturi hic quia voluptatem placeat. Aut voluptatem saepe et. Delectus occaecati in a odit rerum ut aut et. Nam repudiandae architecto vel. Est architecto deleniti repudiandae omnis saepe quia.
Totam sed reprehenderit corporis repudiandae aut voluptatem quaerat. Non asperiores voluptatem vel et et. Nobis nisi nam quos excepturi perferendis.
Voluptatum quasi deserunt deserunt dolorem delectus. Et harum ut dolorem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Et perferendis rerum molestiae veniam. Iure cum corporis optio ea. Reprehenderit maxime et fuga voluptatem qui. Excepturi aut aut modi nisi expedita animi nisi.
Maxime inventore et voluptatem qui. Sit illum dolores et assumenda. Nulla voluptatem quasi harum. Et similique ab voluptatibus iste non tempore.
Vero libero libero omnis quis. Maiores in earum et ullam dignissimos odit illo. Aut expedita nam saepe consequuntur provident ullam omnis. Impedit quia fugit corporis soluta. Ducimus ipsa asperiores labore quibusdam nisi sed.
Dicta autem officiis et iusto corrupti. Rem aut aliquid sunt laudantium. Consequatur repellendus enim non explicabo ipsum. Ducimus qui eos veniam dolores beatae quae quia.